Evidence map›Paper›PMID 36077269›Full record

ArticleInternational journal of molecular sciences2022

Absorption and Metabolism of the Natural Sweeteners Erythritol and Xylitol in Humans: A Dose-Ranging Study.

Valentine Bordier, Fabienne Teysseire, Frank Senner, Götz Schlotterbeck, Jürgen Drewe, Christoph Beglinger, Bettina K Wölnerhanssen, Anne Christin Meyer-Gerspach

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Re-evaluation of erythritol (E 968) as a food additive.EFSA journal. European Food Safety Authority · 2023
    Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Valentine BordierSt. Clara Research Ltd., St. Claraspital, 4002 Basel, Switzerland.
Fabienne TeysseireSt. Clara Research Ltd., St. Claraspital, 4002 Basel, Switzerland.
Frank SennerInstitute for Chemistry and Bioanalytics, School of Life Science, FHNW University of Applied Sciences and Arts Northwestern Switzerland, 4132 Muttenz, Switzerland.
Götz SchlotterbeckInstitute for Chemistry and Bioanalytics, School of Life Science, FHNW University of Applied Sciences and Arts Northwestern Switzerland, 4132 Muttenz, Switzerland.
Jürgen DreweDepartment of Clinical Pharmacology and Toxicology, University Hospital Basel, 4001 Basel, Switzerland.ORCID 0000-0001-5178-7825
Christoph BeglingerSt. Clara Research Ltd., St. Claraspital, 4002 Basel, Switzerland.
Bettina K WölnerhanssenSt. Clara Research Ltd., St. Claraspital, 4002 Basel, Switzerland.ORCID 0000-0003-3134-2743
Anne Christin Meyer-GerspachSt. Clara Research Ltd., St. Claraspital, 4002 Basel, Switzerland.ORCID 0000-0003-4104-8812
University of Basel · CHFHNW University of Applied Sciences and Arts · CHUniversity Hospital of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The natural sweeteners erythritol and xylitol might be helpful to reduce sugar consumption and therefore prevent obesity and diabetes. The aim of the present study was to determine the absorption and metabolization into erythronate of different concentrations of erythritol and xylitol. Seventeen healthy lean participants received intragastric solutions of 10, 25, or 50 g erythritol or 7, 17, or 35 g xylitol on three study days in a randomized order. The study was double blinded with respect to the doses administered. We assessed plasma concentrations of erythritol, xylitol, and erythronate at fixed time intervals after administration with gas chromatography-mass spectrometry. We found: (i) a dose-dependent and saturable absorption of erythritol, (ii) a very low absorption of xylitol, (iii) a dose-dependent metabolization of erythritol into erythronate, and (iv) no metabolization of xylitol into erythronate. The implications of the metabolization of erythritol into erythronate for human health remain to be determined and more research in this area is needed.

Indexed as

Diabetes MellitusXylitolErythritolHumansObesitySweetening AgentsErythritolSweetening AgentsXylitolabsorptiondiabeteserythritolerythronatemetabolismnatural sweetenersobesityxylitol

Identifiers

PMID36077269
PMCPMC9456049
OpenAlexW4293773229

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.